Functional inhibition of G6PT by either CHL or by the ATP-depleting agents 2-DG/5-TG could thus provide a molecular rationale for the role that G6PT may play in the intracellular signalling regulating the high-grade radioresistant glioma cells. The gene discussed is SLC37A4; the disease is central nervous system cancer.